Affordable Access

Assessment of the role of thrombin activatable fibrinolysis inhibitor in retinal vein occlusion.

Authors
Type
Published Article
Journal
Retina
0275-004X
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Volume
27
Issue
5
Pages
578–583
Identifiers
PMID: 17558319
Source
Medline
License
Unknown

Abstract

On the basis of these data, TAFI activity was not found to be a new risk factor for either type of RVO. However, further larger studies may better identify the exact role of TAFI in the pathogenesis of RVO.

Statistics

Seen <100 times